A search for thyroid auto-antibodies is appropriate for all chronic urticarias not responding to first-line therapies with antihistamines, especially when autoimmune urticaria is suspected.

SEATTLE--(BUSINESS WIRE)--Cyrus Biotechnology, an AI-driven therapeutics company, announced today that its CYR212, an engineered next-generation reduced-immunogenicity and half-life extended ...

Moreover, the quality of T-cells from autoimmune patients – already compromised by disease burden or chronic immunosuppressive therapy – can affect treatment efficacy. Allogeneic CAR-T ...

Ignore chronic inflammation at your peril. Recognised as a contributor to many deaths globally, half of these are partly attributable to inflammation-related diseases including heart disease ...

In addition, previous headache diagnoses must be considered and the presence of any comorbid depression or anxiety disorder. These latter disorders seem to occur with greater frequency in IIH ...

Integrating physical exercise programs into a multidisciplinary care plan is highly recommended for the management of juvenile idiopathic arthritis-related chronic pain. Physical exercise ...

Details of the poste Company continues to advance an innovative pipeline of NKT cell regulators for the treatment of high-value inflammatory, fibrotic and autoimmune diseases LA JOLLA, CA ...

Cyrus Biotechnology Inc. has selected CYR-212, an engineered next-generation reduced-immunogenicity and half-life extended immunoglobulin G (IgG) protease, as a clinical development candidate for ...

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...

Although artificial intelligence presents “exciting opportunities,” its use in patient care “must be regulated” to address biases in decision making, said newly appointed American College ...